Regen Lab

OrganizationROROpenAlex

Trials

  • NCT03211650

    Collaborator, Phase 4, Completed, 174 people, Jul 7, 2017

Named in competing interests

Sources: pubmed.ncbi.nlm.nih.gov

Papers